BioOhio-member Great Lakes NeuroTechnologies received a patent covering advances to the company’s wireless patient-worn motion sensors that assess tremor, bradykinesia, rigidity, and dyskinesias associated with diseases like Parkinson’s and essential tremor. The Kinesia and Kinesia HomeView technology platform is FDA approved and has applications for both in-clinic and home-based patient care, as well as telemedicine.
Great Lakes NeuroTechnologies President Joseph Giuffrida said the allowance of the Valley View-based company’s patent claims is a continuation of a commercialization path that began in 2003.
“This heightened intellectual property position builds on and protects our previous commercialization efforts and continued market growth,” he said.
“We have a broad range of patent applications in the pipeline and expect this to be the first of many to cover our innovative product base of movement disorder technologies,” said Executive Vice President Brian Kolkowski. He added that the company is planning international patent filings.
Get more details in the company’s press release.
